Under-use of warfarin for patients with non-valvular atrial fibrillation in Japan

被引:3
|
作者
Inoue, H [1 ]
机构
[1] Toyama Med & Pharmaceut Univ, Dept Internal Med 2, Sugitani, Toyama 9300194, Japan
关键词
anticoagulation; warfarin; embolism; atrial fibrillation;
D O I
10.2169/internalmedicine.43.529
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:529 / 530
页数:2
相关论文
共 50 条
  • [1] Warfarin in non-valvular atrial fibrillation
    Dalby, A. J.
    Wessels, P.
    Opie, L. H.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2013, 103 (12): : 901 - 904
  • [2] Barriers to using warfarin in non-valvular atrial fibrillation
    Gattellari, M
    Zwar, NA
    Worthington, JM
    Middleton, S
    BRITISH MEDICAL JOURNAL, 2006, 332 (7536): : 303 - 304
  • [3] Utilization of warfarin in elderly patients with non-valvular atrial fibrillation.
    Youssef, H
    Pomerantz, SC
    Ciesielski, J
    Cavalieri, TA
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (04) : S112 - S112
  • [4] DISCONTINUATION/INTERRUPTION OF WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Wang, J.
    Qiao, Y.
    Spivey, C. A.
    Liu, X.
    Phatak, H.
    Mardekian, J.
    Claflin, A. B.
    Kachroo, S.
    Abdulsatter, Y.
    Parker, R. B.
    VALUE IN HEALTH, 2014, 17 (07) : A763 - A763
  • [5] Atrial fibrillation, stroke and anticoagulation: under-use of warfarin
    Cabral, NL
    Volpato, D
    Ogata, TR
    Ramirez, T
    Moro, C
    Gouveia, S
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2004, 62 (04) : 1016 - 1021
  • [6] Use of resources and cost implications of stroke prophylaxis with warfarin for patients with non-valvular atrial fibrillation
    Abdelhafiz, AH
    Wheeldon, N
    VALUE IN HEALTH, 2003, 6 (06) : 653 - 654
  • [7] Comparative Effectiveness of Dabigatran versus Warfarin in Patients With Non-Valvular Atrial Fibrillation
    Alonso, Alvaro
    Chen, Lin Y.
    MacLehose, Richard F.
    Lutsey, Pamela L.
    CIRCULATION, 2013, 128 (22)
  • [8] Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban
    Breithardt, Guenter
    Baumgartner, Helmut
    Berkowitz, Scott D.
    Hellkamp, Anne S.
    Piccini, Jonathan P.
    Lokhnygina, Yuliya
    Halperin, Jonathan L.
    Singer, Daniel E.
    Hankey, Graeme J.
    Hacke, Werner
    Becker, Richard C.
    Nessel, Christopher C.
    Mahaffey, Kenneth W.
    Califf, Robert M.
    Fox, Keith A. A.
    Patel, Manesh R.
    HEART, 2016, 102 (13) : 1036 - 1043
  • [9] WARFARIN DISCONTINUATION AND STROKE RISK AMONG PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Wang, J.
    Qiao, Y.
    Spivey, C. A.
    Liu, X.
    Phatak, H.
    Mardekian, J.
    Claflin, A. B.
    Kachroo, S.
    Abdulsatter, Y.
    Parker, R. B.
    VALUE IN HEALTH, 2014, 17 (03) : A8 - A9
  • [10] Persistence Among Patients with Non-Valvular Atrial Fibrillation Beginning Dabigatran or Warfarin
    Francis, Kevin M.
    Siu, Kimberly
    Yu, Chen
    Alvrtsyan, Hasmik
    Rao, Yajing
    Walker, David R.
    Sander, Stephen D.
    Zalesak, Martin
    Miyasato, Gavin
    Sanchez, Herman
    BLOOD, 2012, 120 (21)